(Q42542039)

English

Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group

scientific article published on May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 November 2017

Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group (English)

1 reference

Europe PubMed Central

2 November 2017

0 references

multicenter clinical trial

0 references

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

author name string

Marberger MJ

1

1 reference

Europe PubMed Central

2 November 2017

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

2 November 2017

1 reference

Europe PubMed Central

2 November 2017

51

1 reference

Europe PubMed Central

2 November 2017

5

1 reference

Europe PubMed Central

2 November 2017

677-686

1 reference

Europe PubMed Central

2 November 2017

The prevalence of prostatism: a population-based survey of urinary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Finasteride: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of a symptoms questionnaire for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of Prostatic Weight in Prostatism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of prostatism: risk factors for acute urinary retention

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostatectomy: patients' perception and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900094-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(98)00094-6

1 reference

Europe PubMed Central

2 November 2017

1 reference

Europe PubMed Central

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42542039&oldid=1961261140"